Aizenberg, D., Zemishlany, Z. & Weizman, A. (1995) Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clinical Neuropharmacology, 18, 320–324.
Baldwin, D. & Johnson, N. (1995) Tolerability and safety of citalopram. Review of Contemporary Pharmacotherapy, 6, 315–325.
Balon, R. (1996) Intermittent amantadine for fluoxetine-induced anorgasmia. Journal of Sex and Marital Therapy, 22, 290–292.
Benazzi, F. (1995) Involuntary sperm emission with fluoxetine. Canadian Journal of Psychiatry, 40, 431.
Berk, M. & Acton, M. (1997) Citalopram-associated clitoral priapism: a case series. International Clinical Psychopharmacology, 12, 121–122.
Berzewski, H., Van Moffaert, M. & Gagiano, C. A. (1997) Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes. European Neuropsychopharmacology, 7, S37–S47.
Charles, F., Weber, C. & Weber, S. S. (1993) Paroxetine: A selective serotonin reuptake inhibiting antidepressant. Annals of Pharmacotherapy, 27, 1212–1220.
Doogan, D. P. & Caillard, V. (1988) Sertraline: a new antidepressant. Journal of Clinical Psychiatry, 49, 46–51.
Dorevitch, A. & Davis, H. (1994) Fluvoxamine-associated sexual dysfunction. Annals of Pharmacotherapy, 28, 872–874.
Dubovsky, S. L. & Thomas, M. (1995) Serotonergic mechanisms and current future psychiatric practice. Journal of Clinical Psychiatry, 56 (suppl.), 38–48.
Gitlin, M. J. (1994) Psychotropic medications and their effects on sexual dysfunction: Diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry, 55, 406–413.
Hawley, C. & Smith, V. (1994) Review of a paper entitled “Effects of antidepressants on sexual function”. Medical Dialogue, 4, 1–4.
Herman, J. B., Brotman, A. W., Pollack, M. H., et al (1990) Fluoxetine-induced sexual dysfunction. Journal of Clinical Psychiatry, 51, 25–27.
Hong, S. L., Dong, H. S., Chan-Hyung, K., et al (1996) An open clinical trial of fluoxetine in the treatment of premature ejaculation. Journal of Clinical Psychopharmacology, 16, 379–382.
Jacobsen, F. M. (1992) Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. Journal of Clinical Psychiatry, 53, 119–122.
Lauerma, H. (1995) A case of moclobemide-induced hyperorgasmia. International Clinical Psychopharmacology, 10, 123–124.
Lauerma, H. (1996) Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatrica Scandinavica, 93, 69–70.
Mendels, J., Johnston, R., Mattes, J., et al (1993) Efficacy and safety of b.i.d. doses of venlafaxine in a dose response study. Psychopharmacology Bulletin, 29, 169–174.
Michael, A. & Owen, A. (1997) Venlafaxine-induced increased libido and spontaneous erections. British Journal of Psychiatry, 170, 193.
Montgomery, S. A. (1995) Safety of mirtazepine: a review. International Clinical Psychopharmacology, 4, 37–45.
Morris, P. L. (1991) Fluoxetine and orgasmic sexual experiences. International Journal of Psychiatry in Medicine, 21, 379–382.
Mucci, M. (1997) Reboxetine: a review of antidepressant tolerability. Journal of Psychopharmacology, 11, 533–537.
Murray, M. J. & Hooberman, D. (1993) Fluoxetine and prolonged erection. American Journal of Psychiatry, 150, 167–168.
Nelson, E. B., Keck, P. E. Jr & McElroy, S. L. (1997) Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisitron.
Journal of Clinical Psychiatry, 58, 496–497.
Philipp, M., Kohnen, R. & Benkert, O. (1993) A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. International Clinical Psychopharmacology, 7, 149–153.
Preskorn, S. H. (1995) Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. Journal of Clinical Psychiatry, 56, 12–21.
Reynolds, R. D. (1997) Sertraline-induced anorgasmia treated with intermittent nefazodone (letter). Journal of Clinical Psychiatry, 58, 89.
Rothschild, A. J. (1995) Selective serotonin reuptake inhibitor - induced sexual dysfunction: efficacy of a drug holiday. American Journal of Psychiatry, 152, 1514–1516.
Shrivastava, R. K., Shrivastava, S., Overweg, N., et al (1995) Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology, 15, 83–84.
Waldinger, M. D. (1996) Use of psychoactive agents in the treatment of sexual dysfunction. CNS Drugs, 6, 204–216.
Waldinger, M. D., Hengreveld, M. W. & Zwinderman, A. H. (1997) Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose response study. British Journal of Urology, 79, 592–595.